These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18782439)

  • 1. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.
    Karsdal MA; Byrjalsen I; Riis BJ; Christiansen C
    BMC Clin Pharmacol; 2008 Sep; 8():5. PubMed ID: 18782439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of food intake on the bioavailability and efficacy of oral calcitonin.
    Karsdal MA; Byrjalsen I; Azria M; Arnold M; Choi L; Riis BJ; Christiansen C
    Br J Clin Pharmacol; 2009 Apr; 67(4):413-20. PubMed ID: 19371314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy.
    Karsdal MA; Byrjalsen I; Henriksen K; Riis BJ; Christiansen C
    Eur J Clin Pharmacol; 2010 Jan; 66(1):29-37. PubMed ID: 19813008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
    Karsdal MA; Byrjalsen I; Henriksen K; Riis BJ; Lau EM; Arnold M; Christiansen C
    Osteoarthritis Cartilage; 2010 Feb; 18(2):150-9. PubMed ID: 19747581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitonin.
    Karsdal MA; Byrjalsen I; Henriksen K; Riis BJ; Christiansen C
    J Clin Pharmacol; 2009 Feb; 49(2):229-34. PubMed ID: 19179298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin.
    Karsdal MA; Byrjalsen I; Riis BJ; Christiansen C
    BMC Clin Pharmacol; 2008 Dec; 8():12. PubMed ID: 19055791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.
    Karsdal MA; Byrjalsen I; Bay-Jensen AC; Henriksen K; Riis BJ; Christiansen C
    BMC Musculoskelet Disord; 2010 Jun; 11():125. PubMed ID: 20565725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.
    Karsdal MA; Henriksen K; Bay-Jensen AC; Molloy B; Arnold M; John MR; Byrjalsen I; Azria M; Riis BJ; Qvist P; Christiansen C
    J Clin Pharmacol; 2011 Apr; 51(4):460-71. PubMed ID: 20660294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
    Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
    Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
    Hinchcliffe M; Jabbal-Gill I; Smith A
    J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers.
    Buclin T; Cosma Rochat M; Burckhardt P; Azria M; Attinger M
    J Bone Miner Res; 2002 Aug; 17(8):1478-85. PubMed ID: 12162502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nasal salmon calcitonin on calcium and bone metabolism.
    Thamsborg G
    Dan Med Bull; 1999 Apr; 46(2):118-26. PubMed ID: 10327295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.
    Bagger YZ; Tankó LB; Alexandersen P; Karsdal MA; Olson M; Mindeholm L; Azria M; Christiansen C
    Bone; 2005 Sep; 37(3):425-30. PubMed ID: 16005273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin load test to assess the efficacy of salmon calcitonin.
    Stepan JJ; Zikán V
    Clin Chim Acta; 2003 Oct; 336(1-2):49-55. PubMed ID: 14500034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma type 1 collagen cross-linked C-telopeptide: a sensitive marker of acute effects of salmon calcitonin on bone resorption.
    Zikán V; Stepan JJ
    Clin Chim Acta; 2002 Feb; 316(1-2):63-9. PubMed ID: 11750275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.